Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 325-332, March 2010

2-Deoxy-d-ribose induces cellular damage by increasing oxidative stress and protein glycation in a pancreatic β-cell line

  • Gwanpyo Koh

      Affiliations

    • Department of Internal Medicine, Jeju National University School of Medicine, Jeju 690-756, Republic of Korea
    • Institute of Medical Science, Jeju National University, Jeju 690-756, Republic of Korea
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Jeju National University School of Medicine, Jeju 690-756, Republic of Korea. Tel.: +82 64 754 1110; fax: +82 64 754 1109.
  • ,
  • Dae-Ho Lee

      Affiliations

    • Department of Internal Medicine, Jeju National University School of Medicine, Jeju 690-756, Republic of Korea
  • ,
  • Jeong-taek Woo

      Affiliations

    • Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Dongdaemoon-gu, Seoul 130-702, Republic of Korea

Received 29 April 2009; accepted 29 July 2009. published online 30 September 2009.

Abstract 

2-Deoxy-d-ribose (dRib) is a sugar with a high reducing capacity. We previously reported that dRib induced damage in pancreatic β-cells. The aim of this study was to investigate the mechanism of dRib-induced β-cell damage. 2-Deoxy-d-ribose provoked cytotoxicity and apoptosis within 24 hours in HIT-T15 cells. Three antiglycating agents—diethylenetriaminepentaacetic acid, aminoguanidine, and pyridoxamine—dose dependently inhibited dRib-triggered cytotoxicity and significantly suppressed apoptosis induced by dRib. 2-Deoxy-d-ribose increased intracellular reactive oxygen species and protein carbonyl levels in a dose-dependent manner. Diethylenetriaminepentaacetic acid and aminoguanidine significantly reduced dRib-induced rises in intracellular reactive oxygen species. All 3 inhibitors decreased the production of intracellular protein carbonyls by dRib. On incubation with albumin, dRib increased dicarbonyl and advanced glycation end product formation. Aminoguanidine and pyridoxamine significantly decreased the dicarbonyl and advanced glycation end product augmentations. These results suggest that both oxidative stress and protein glycation are important mechanisms of dRib-induced damage in a pancreatic β-cell line.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(09)00319-9

doi:10.1016/j.metabol.2009.07.028

Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 325-332, March 2010